P1158: REAL-WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND TREATMENT OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) BY LINE OF THERAPY (LOT)

• Helmneh Sineshaw,
• Christina Zettler,
• Jennifer Prescott,
• Mahek Garg,
• Samhita Chakraborty,
• Eric Sarpong,
• Andrew Belli,
• Claire Bai,
• Ching-Kun Wang

Affiliations

Helmneh Sineshaw

1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Christina Zettler

2 Cota, Inc, New York, United States

Jennifer Prescott

1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Mahek Garg

1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Samhita Chakraborty

1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Eric Sarpong

1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Andrew Belli

2 Cota, Inc, New York, United States

Claire Bai

2 Cota, Inc, New York, United States

Ching-Kun Wang

2 Cota, Inc, New York, United States